Multimodal evoked potentials to assess the evolution of multiple sclerosis: A longitudinal study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 9, 2006, Pages 1030-1035

  Leocani, L ^a   Rovaris, M ^a   Boneschi, F M ^a   Medaglini, S ^a   Rossi, P ^a   Martinelli, V ^a   Amadio, S ^a   Comi, G ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; EVOKED RESPONSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE INJURY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; CLASSIFICATION; CLINICAL TRIAL; DISABLED PERSON; DISEASE COURSE; HOSPITALIZATION; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKER;

ADULT; BIOLOGICAL MARKERS; DISABLED PERSONS; DISEASE PROGRESSION; EVOKED POTENTIALS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33747406972     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.086280     Document Type: Article

References (40)

1. Comi G, Locatetli T, Leocani L, et at. Can evoked potentials be useful in monitoring multiple sclerosis evolution? Electroencephalogr Clin Neurophysiol Suppl 1999;50:349-57.
2. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85.
3. Bitsch A, Schuchardt J, Bunkowski S, et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000;123:1174-83.
4. McDonald WI, Sears TA. The effects of experimental demyelination on conduction in the central nervous system. Brain 1970;93:583-98.
5. McDonald W, Compston D, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neural 2001;50:121-7.
6. Poser CM. The diagnosis and management of multiple sclerosis. Acta Neurol Scand 2005;112:199-201.
7. Leocani L, Martinelli V, Natali-Sora MG, et al. Somatosensory evoked potentials and sensory involvement in multiple sclerosis: comparison with clinical findings and quantitative sensory tests. Mult Scler 2003;9:275-9.
8. Fukutake T, Kuwabara S, Kaneko M, et al. Sensory impairments in spinal multiple sclerosis: a combined clinical, magnetic resonance imaging and somatosensory evoked potential study. Clin Neurol Neurosurg 1998;100:199-204.
9. Weinstock-Guttman B, Baier M, Stockton R, et al. Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis. Mult Scler 2003;9:529-34.
10. Van der Kamp W, Maertens de Noordhout A, Thompson PD, et al. Correlation of phasic muscle strength and corticomotoneuron conduction time in multiple sclerosis. Ann Neurol 1991;29:6-12.
11. Fuhr P, Borggrefe-Chappuis A, Schindler C, et al. Visual and motor evoked potentials in the course of multiple sclerosis. Brain 2001;124:2162-8.
12. O'Connor P, Marchetti P, Lee L, et al. Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis. Ann Neurol 1998;44:404-7.
13. Matthews VB, Small DG. Serial recording of visual and somatosensory evoked potentials in multiple sclerosis. J Neurol Sci 1979;40:11-21.
14. Aminoff MJ, Davis SL, Panitch HS. Serial evoked potentials studies in patients with definite multiple sclerosis. Arch Neurol 1984;41:1197-202.
15. Davis SL, Aminoff MJ, Panitch HS. Clinical correlations of serial somatosensory evoked potentials in multiple sclerosis. Neurology 1985;35:359-65.
16. Sater RA, Rostami AM, Galetta S, et al. Serial evoked potential studies and MRI imaging in chronic progressive multiple sclerosis. J Neural Sci 1999;171:79-83.
17. De Weerd AW, Jonkman EJ. Changes in visual and short latency somatosensory evoked potentials in patients with multiple sclerosis. In: Courjon J, Mauguière F, Revol N, eds. Clinical applications of evoked potentials in neurology. New York: Raven Press, 1982:527-34.
18. Walsh JC, Garrick R, Cameron J, et al. Evoked potentials changes in clinically definite multiple sclerosis: a two years follow up study. J Neurol Neurosurg Psychiatry 1982;45:494-500.
19. Ghezzi A, Zaffaroni M, Caputo D, et al. Evaluation of evoked potentials and lymphocyte subsets as posible markers of multiple sclerosis: one year follow-up of 30 patients. J Neural Neurosurg Psychiatry 1986;49:913-9.
20. Nuwer MR, Packwood JW, Myers LW, et al. Evoked potentials predict the clinical changes in a multiple sclerosis drug study. Neurology 1987;37:1754-61.
21. Andersson T, Siden A. Multimodality evoked potentials and neurological phenomenology in patients with multiple sclerosis and potentially related conditions. Electromyogr Clin Neurophysiol, 1991;31:109-17.
22. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neural 1983;13:227-31.
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-52.
24. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-11.
25. Deuschl G, Eisen A. Recommendations for the practice of clinical neurophysiology: Guidelines of the International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol 1999;52(Suppl):192-211.
26. European study group on Interferon beta-1 b in secondary progressive MS. Placebo-controlled multicenter randomised trial of Interferon beta-1 b in treatment of secondary progressive multiple sclerosis. Lancet 1998;352:1491-7.
27. Chiappa KH. Pattern shift visual, brainstem auditory and short latency somatosensory evoked potentials in multiple sclerosis. Neurology 1980;30:110-23.
28. Khosbin S, Hallett M. Multimodality evoked potentials and blink reflex in multiple sclerosis. Neurology 1981;31:138-44.
29. Trojaborg W, Petersen E. Visual and somatosensory evoked potentials in multiple sclerosis. J Neurol Neurosurg Psychiatry 1979;42:323-30.
30. Comi G, Martinelli V, Medaglini S, et al. Correlation between multimodal evoked potentials and magnetic resonance imaging in multiple sclerosis. J Neurol 1989;236:4-8.
31. Dawson JW. The histology of disseminated sclerosis (part 1, 2, 3). Edinburgh Med J N S 1916;17:311-410.
32. Onofrj M, Thomas A, lacono D, et al. Age-related changes of evoked potentials. Neurophysiol Clin 2001;31:83-103.
33. Celesia GG. Visual evoked potentials in clinical neurology. In: Aminoff M, eds. Electrodiagnosis in clinical neurology. New York: Churchill-Livingstone, 1992:467-89.
34. Ingram DA, Thomson AJ, Swash M. Central motor conduction in multiple sclerosis: evaluation of abnormalities revealed by transcutaneous magnetic stimulation of the brain. J Neurol Neurosurg Psychiatry 1988;51:487-94.
35. Comi G, Locatelli T, Leocani L. Confronta tra potenziali evocati somatosensoriali e test auantitativi delle sensibilità nei pazienti con sclerosi multipla. In: Comi G, eas. I potenziali evocati nella sclerosi multipla. Italia: Springer-Verlag, 1995:85-90.
36. Filippi M, Campi A, Mammi S, et al. Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. J Neural Neurosurg Psychiatry 1995;58:31-7.
37. Koehler J, Faldum A, Hopf HC. EDSS correlated analysis of median nerve somatosensory evoked potentials in multiple sclerosis. Neural Sci 2000;21:217-21.
38. Hickman SJ, Brierley CM, Brex PA, et al. Continuing optic nerve atrophy following optic neuritis: a serial MRI study. Mult Scler 2002;8:339-42.
39. Fisher E, Rudick RA, Simon JH, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002;59:1412-20.
40. Rovaris M, Agosta F, Sormani MP, et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003;126:2323-32.